Skip to main content
April 9, 2025

U.S. v Skrmetti: Arguments and Consequences for Transgender Health Care

Location
HSPH, Kresge G1, Snyder Auditorium
677 Huntington Ave
Boston, MA United States

Event Type

1:00 pm 1:50 pm

Event Type

From Around the School, Lectures/Seminars/Forums

Join us! Alejandra Caraballo will discuss how the U.S. Supreme Court decision in U.S. v. Skrmetti will impact access to gender-affirming health care for transgender people.  

Lunch will be served.

This event is open to the public. Registration is required.

Public parking is limited, so use of public transportation or ride services is recommended.

Speaker Information

Organizers

Co-sponsored by: Harvard T.H. Chan School of Public Health Women, Gender, and Health Interdisciplinary Concentration & Department of Epidemiology & Office of Diversity and Inclusion; Harvard Medical School Office of Recruitment and Multicultural Affairs & Office of Diversity Inclusion and Community Partnership; Harvard College Office of BGLTQ Student Life; SOGIE Health Equity Research Collaborative; Inclusion, Diversity, and Equity at Dana-Farber

Harvard Chan School hosts a diverse array of speakers who are invited to share their scholarly research and perspectives; they do not speak for the School or Harvard University.

December 4, 2024

#SexCells: Investigating parental toxicant exposures in the etiology of autism and neurodevelopmental disorders with Jill Escher

Please join the Harvard Chan NIEHS Center for Environmental Health for a talk by Jill Escher, JD, MA, on December 4, 2024 at 2 pm ET on Zoom.

Visit hsph.me/NIEHS-seminar to register.

In a seeming paradox, research has found steadily increasing rates of autism while also finding the condition is strongly heritable. These phenomena may be at least partly reconciled, however, when viewed through the lens of genetic (germline) toxicology. In this presentation research advocate Jill Escher, MA, JD, shares the latest research showing how certain toxicant exposures, such as modern halogenated general anesthesia, to the parents can raise risk for neurodevelopmental pathology in the offspring, via parental germline perturbations, while also discussing implications for epidemiological investigations.

Jill Escher, JD, MA, is the founder of Escher Fund for Autism, a fund that supports autism programs and research. She also serves as president of the National Council on Severe Autism, secretary and past president of Autism Society San Francisco Bay Area, and co-chair of the Germ Cell SIG of the Environmental Mutagenesis and Genomics Society. Her work has been published in Environmental Epigenetics, Biology of Reproduction, Environmental and Molecular Mutagenesis, and the Journal of Autism and Developmental Disorders. She is a former lawyer and is the mother of two children with idiopathic profound autism, Jonathan, 25, and Sophie, 18. More info: jillescher.com and escherfund.org.